Cargando…
Salivaomics as a Potential Tool for Predicting Alzheimer’s Disease During the Early Stages of Neurodegeneration
BACKGROUND: The metabolomic and proteomic basis of mild cognitive impairment (MCI) and Alzheimer’s disease (AD) is poorly understood and the relationships between systemic abnormalities in metabolism and AD/AMCI pathogenesis are unclear. OBJECTIVE: The aim of the study was to compare the metabolomic...
Autores principales: | François, Maxime, Karpe, Avinash, Liu, Jian-Wei, Beale, David, Hor, Maryam, Hecker, Jane, Faunt, Jeff, Maddison, John, Johns, Sally, Doecke, James, Rose, Stephen, Leifert, Wayne R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461673/ https://www.ncbi.nlm.nih.gov/pubmed/34151801 http://dx.doi.org/10.3233/JAD-210283 |
Ejemplares similares
-
Multi-Omics, an Integrated Approach to Identify Novel Blood Biomarkers of Alzheimer’s Disease
por: François, Maxime, et al.
Publicado: (2022) -
Salivary inflammatory biomarkers are predictive of mild cognitive impairment and Alzheimer’s disease in a feasibility study
por: McNicholas, Kym, et al.
Publicado: (2022) -
A Review of Analytical Techniques and Their Application in Disease Diagnosis in Breathomics and Salivaomics Research
por: Beale, David J., et al.
Publicado: (2016) -
Salivaomics: The current scenario
por: Shah, Sonalee
Publicado: (2018) -
Emerging technologies for salivaomics in cancer detection
por: Kaczor‐Urbanowicz, Karolina Elżbieta, et al.
Publicado: (2016)